Inactivation of recombinant monocyte cAMP-specific phosphodiesterase by camp analog, 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic monophosphate

Blood

Volumn 89, Issue 3, 1997, Pages 1019-1026

  Omburo, George A ^b   Torphy, Theodore J ^b   Scott, Gilbert ^b   Jacobitz, Susanne ^b   Colman, Roberta F ^b   Colman, Robert W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP; DENBUFYLLINE; ROLIPRAM; SODIUM BOROHYDRIDE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; COMPETITIVE INHIBITION; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME CONFORMATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

EID: 0030998695     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.3.1019     Document Type: Article

References (42)

1. Beavo JA: Multiple isozymes of cyclic nucleotide phosphodiesterase. Adv Second Messenger Phosphoprotein Res 22:1, 1988
2. Beavo J: Multiple phosphodiesterase isoenzymes: Background, nomenclature and implications, in Beavo J, Houslay MD (eds): Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action, New York, NY, Wiley, 1990, p 3
3. Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. [Review]. Trends Pharmacol Sci 11:150, 1990
4. Beavo JA, Conti M, Heaslip RJ: Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46:399, 1994
5. Novack JP, Charbonneau H, Bentley JK, Walsh KA, Beavo JA: Sequence comparison of calmodulin-dependent cyclic nucleotide phosphodiesterase. Biochemistry 30:7940, 1991
6. Charbonneau H, Prusti RK, LeTrong H, Sonnenburg WK, Mullaney PJ, Walsh KA, Beavo JA: Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases. Proc Natl Acad Sci USA 87:288, 1990
7. Stroop SD, Charbonneau H, Beavo JA: Direct photolabeling of the cGMP-stimulated cyclic nucleotide phosphodiesterase. J Biol Chem 264:13718, 1989
8. Jin SL, Swinnen JV, Conti M: Characterization of the structure of a low Km, rolipram-sensitive cAMP phosphodiesterase. Mapping of the catalytic domain. J Biol Chem 267:18929, 1992
9. McHale MM, Cieslinski LB, Eng WK, Johnson RK, Torphy TJ, Livi GP: Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast. Mol Pharmacol 39:109, 1991
10. Francis SH, Colbran JL, McAllister-Lucas LM, Corbin JD: Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase. J Biol Chem 269:22477, 1994
11. Omburo GA, Brickus T, Ghazaleh FA, Colman RW: Divalent metal cation requirement and possible classification of cGMP-inhibited phosphodiesterase as a metallohydrolase. Arch Biochem Biophys 323:1, 1995
12. Schudt C, Winder S, Muller B, Ukena D: Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem Pharmacol 42:153, 1991
13. Torphy TJ, Livi GP, Balcarek JM, White JR, Chilton FH, Undem BJ: Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma. [Review]. Adv Second Messenger Phosphoprotein Res 25:289, 1992
14. Ahn HS, Foster M, Foster C, Sybertz E, Wells JN: Evidence for essential histidine and cysteine residues in calcium/calmodulin-sensitive cyclic nucleotide phosphodiesterase. Biochemistry 30: 6754, 1991
15. Ghazaleh FA, Omburo GA, Colman RW: Evidence for the presence of essential histidine and cysteine residues in platelet cGMP-inhibited phosphodiesterase. Biochem J 317:495, 1996
16. Jakoby WB, Wilcheck M: Affinity labeling. Methods Enzymol 46:1, 1977
17. Colman RF: Affinity labeling, in Creighton TE (ed): Protein Function (practical approach series). Oxford, UK, IRL, 1990, p 77
18. Haley BE: Photoaffinity labeling of adenosine 3′,5′-cyclic monophosphate binding sites of human red cell membranes. Biochemistry 14:3852, 1975
19. Pomerantz AH, Rudolph SA, Haley BE, Greengard P: Photoaffinity labeling of a protein kinase from bovine brain with 8-azido-adenosine 3′,5′-monophosphate. Biochemistry 14:3858, 1975
20. Christensen LF, Meyer RB Jr, Miller JP, Simon LN, Robins RK: Synthesis and enzymic activity of 8-acyl and 8-alkyl derivatives of guanosine 3, 5-cyclic phosphate. Biochemistry 14:1490, 1975
21. Miller JP, Boswell KH, Meyer RB Jr, Christensen LF, Robins RK: Synthesis and enzymatic and inotropic activity of some new 8-substituted and 6,8-disubstituted derivatives of adenosine cyclic 3′,5′-monophosphate. J Med Chem 23:242, 1980
22. Meyer RB, Uno H, Robins RK, Simon LN, Miller JP: 2-substituted derivatives of adenosine and inosine cyclic 3′,5′-phosphate synthesis enzymatic activity and analysis of the structural requirements of the binding locale of the 2-substituent on bovine brain protein kinase. Biochemistry 14:3315, 1975
23. Dreyfuss G, Schwartz K, Blout ER, Barrio JR, Liu FT, Leonard NJ: Fluorescent photoaffinity labeling: adenosine 3′,5′-cyclic monophosphate receptor sites. Proc Natl Acad Sci USA 75:1199, 1978
24. Severin ES, Nesterova MV, Sashchenko LP, Rasumova VV: Investigation of the adenosine 3′, 5′-cyclic phosphate binding site of pig brain histone kinase with the aid of some analogues of adenosine 3′, 5′-cyclic phosphate. Biochim Biophys Acta 384:413, 1975
25. Grant PG, DeCamp DL, Bailey JM, Colman RW, Colman RF: Three new potential cAMP affinity labels. Inactivation of human platelet low Km cAMP phosphodiesterase by 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3′,5′-cyclic monophosphate. Biochemistry 29:887, 1990
26. Omburo G, Torphy T, Scott G, Colman RF, Colman RW: Inactivation of leukocyte cyclic AMP specific (type IV) phosphodiesterase by the affinity label 8-[4-bromo-2,3-dioxobutyl)thio]cAMP (8-BDB-TcAMP). FASEB J 8:A371, 1994 (abstr, suppl)
27. Livi GP, Kmetz P, McHale MM, Cieslinski LB, Sathe GM, Taylor DP, Davis RL, Torphy TJ, Balcarek JM: Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase. Mol Cell Biol 10:2678, 1990
28. Penefsky HS: A centrifuged-column procedure for the measurement of ligand binding by beef heart F1. Methods Enzymol 56:527, 1979
29. Stoscheck CM: Protein assay sensitive at nanogram levels. Anal Biochem 160:301, 1987
30. Torphy TJ, Zhou HL, Cieslinski LB: Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J Pharmacol Exp Ther 263:1195, 1992
31. Kamp RM: Direct micro-sequence analysis of peptides, in Liebold BW, Salnikow J, Erdmann VA (eds): Advanced Methods in Protein Microsequence Analysis. New York, NY, Springer-Verlag, 1986, p 1
32. Le Huerou I, Wicker C, Guilloteau P, Toullec R, Puigserver A: Isolation and nucleotide sequence of cDNA clone for bovine pancreatic anionic trypsinogen. Structural identity within the trypsin family. Eur J Biochem 193:767, 1990
33. Grant PG, Colman RW: Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry 23:1801, 1984
34. Torphy TJ, Undem BJ: Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. [Review]. Thorax 46:512, 1991
35. Hartman FC: Haloketones as affinity labeling reagents. Methods Enzymol 46:130, 1977
36. DeCamp DL, Colman RF: Identification of tyrosine and lysine peptides labeled by 5′-p-fluorosulfonylbenzoyl adenosine in the active site of pyruvate kinase. J Biol Chem 261:4499, 1986
37. Batra SP, Colman RF: Isolation and identification of cysteinyl peptide labeled by 6-[( 4-bromo-2,3-dioxobutyl)thio]-6-deaminoadenosine 5′-diphosphate in the reduced diphosphopyridine nucleotide inhibitory site of glutamate dehydrogenase. Biochemistry 25:3508, 1986
38. Batra SP, Lark RH, Colman RF: Identification of histidyl peptide labeled by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5′-monophosphate in an APD regulatory side of glutamate dehydrogenase. Arch Biochem Biophys 270:277, 1989
39. Vollmer SH, Colman RF: Cysteinyl peptides of rabbit muscle pyruvate kinase labeled by the affinity label 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 5′-triphosphate. Biochemistry 29:2495, 1990
40. Huang YC, Bailey JM, Colman RF: Inactivation of NAD-dependent isocitrate dehydrogenase by affinity labeling of the allosteric ADP site by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5′-diphosphate. J Biol Chem 261:14100, 1986
41. Huang YC, Colman RF: Aspartyl peptide labeled by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5′-diphosphate in the allosteric ADP site of pig heart NAD+-dependent isocitrate dehydrogenase. J Biol Chem 264:12208, 1989
42. Katusz RM, Colman RF: S-(4-Bromo-2,3-dioxobutyl)glutathione: A new affinity label for the 4-4 isoenzyme of rat liver glutathione S-transferase. Biochemistry 30:11230, 1991